# Sublingual Misoprostol In Medical Treatment of First Trimester Missed Miscarriage

> **NCT05103098** · NA · UNKNOWN · sponsor: **hany farouk** · enrollment: 200 (estimated)

## Conditions studied

- Miscarriage

## Interventions

- **DRUG:** misoprostol 400 mcg
- **DRUG:** misoprostol 800 mcg

## Key facts

- **NCT ID:** NCT05103098
- **Lead sponsor:** hany farouk
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05103098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05103098, "Sublingual Misoprostol In Medical Treatment of First Trimester Missed Miscarriage". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05103098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
